Olive builds artificial intelligence and RPA solutions that empower healthcare organizations to improve efficiency and patient care while reducing costly administrative errors.
Olive puts a blue collar on artificial intelligence and lets it manage the repetitive, high-volume tasks and workflows that machines do best, leaving the tasks that require creativity, empathy, and passion to people.
What Makes Olive Different
Artificial Intelligence as a Service (AIaaS)
Olive scopes, builds, implements, and supports your workflows for one price. No working with consultants, integrators, or other software companies–we are your single point of contact.
Focus in Healthcare
Since the beginning, Olive has had a mission to fundamentally change healthcare. We have passed our expansive knowledge of healthcare operations and security protocols onto Olive, freeing up your team members to focus on patient care and customer service.
Olive has advanced machine intelligence capabilities that can be used to enhance bots. As part of our AI as a Service model, customers can leverage machine learning models to solve complex problems in their processes. Bots have the ability to learn by collecting data from humans in situations where logic is insufficient.
Made in the USA
Olive is based in the United States with no offshore development. Our incredible team resides in Columbus, Ohio, where Olive is developed and tested.
Chief Operating Officer
Chief Marketing Officer
Board of Directors
Sean is a lifelong technologist who grew up in a small, rural town in Ohio and started his career in the U.S. intelligence community, holding leadership positions in the Department of Defense and the National Security Agency. Sean served five combat tours in Iraq and Afghanistan, and was awarded the Defense Meritorious Service Medal and Bronze Star Medal for his service. After government service, Sean started his life as an entrepreneur, and has founded several technology companies dealing with big data, advanced analytics, entity resolution, and most recently, artificial intelligence. Sean has raised over $70M in venture capital, and is now a leading expert in applying AI in healthcare. He is a graduate of Miami University with an Honorary Doctorate of Public Service from the University of Rio Grande, and was previously named Ernst and Young Entrepreneur of the Year.
Dr. David Agus
Physician and Professor, USC
Dr. Agus is a professor of medicine and engineering at the University of Southern California (USC) Keck School of Medicine and Viterbi School of Engineering and the CEO and founding director of USC’s Lawrence J. Ellison Institute for Transformative Medicine. He is one of the world’s leading physicians specializing in treating patients with advanced forms of cancer, is the co-founder of several personalized medicine companies and has served in leadership roles at the World Economic Forum. Over the years he has treated a number of high-profile patients, including Steve Jobs and Lance Armstrong. Dr. Agus holds degrees from Princeton University and the University of Pennsylvania School of Medicine.
Principal, Healthcare, Oak HC/FT
Billy joined Oak HC/FT as a Principal in 2018. Prior to joining Oak HC/FT, Billy was with Francisco Partners, a technology-focused private equity firm, where he helped lead investments and served on the boards of several companies across healthcare, fintech, and application software. Billy was previously with TPG Growth, the early stage investment platform of TPG Capital, where he focused on investments in healthcare, software, financial services, and consumer products. Billy began his career in the Media & Communications investment banking group at UBS and also worked with the lending platform Funding Circle during the early stages of its US operations. Billy graduated cum laude from Yale University with a BA in History and earned an MBA from the Stanford Graduate School of Business, where he was an Arjay Miller Scholar.
Investment Director, Ascension Ventures
John Kuelper joined Ascension Ventures in 2014 as a Kauffman Fellow. John is Founder and President of Qualia Holdings LLC, a platform for systems biology and therapeutic ventures. He has advised or worked for several investment firms (Adams Street Partners, Sterling Partners, Abundant Venture Partners), medical technology companies (Stereotaxis, Orpheden Therapeutics), and non-profits (The Kresge Foundation, the Blue Cross and Blue Shield Association). John began his career as a medical researcher studying computational neuroscience and medical robotics and has over fifteen years of experience as a commercial software developer. John earned JD and MBA degrees from the Northwestern University Pritzker School of Law and Kellogg School of Management where he graduated with honors and was elected Beta Gamma Sigma (top 10% of class). He earned a BA in cognitive neuroscience from Washington University in St. Louis, graduating magna cum laude. In 2014 he was elected to the Kauffman Fellows Society. In his spare time, John enjoys hiking and camping with his two dogs and listening to live music.
Partner, Drive Capital
A native of Cincinnati, Chris built his career investing in emerging technology and healthcare companies. Prior to co-founding Drive Capital, Chris was at Sequoia Capital for six years where he led and managed the firm’s growth investing practice. His investments include LitePoint (Teradyne), Klarna, Weebly, Electronic Arts (EA – NASDAQ), GSI Commerce (EBay) and eMeter (Siemens). Before Sequoia, Chris was an investor with Technology Crossover Ventures. Chris briefly dropped out of Yale to compete on the professional squash circuit, where he quickly learned he was better suited to work with entrepreneurs.